GOLDMAN SACHS GROUP INC - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 86 filers reported holding FLEXION THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$636,000
-93.1%
104,244
-90.6%
0.00%
-100.0%
Q2 2021$9,169,000
+0.6%
1,114,145
+9.4%
0.00%0.0%
Q1 2021$9,115,000
-4.5%
1,018,351
+23.1%
0.00%0.0%
Q4 2020$9,549,000
+0.8%
827,527
-9.1%
0.00%
-33.3%
Q3 2020$9,476,000
-0.8%
910,296
+25.4%
0.00%0.0%
Q2 2020$9,548,000
+1064.4%
726,026
+597.1%
0.00%
Q1 2020$820,000
-75.7%
104,147
-36.0%
0.00%
-100.0%
Q4 2019$3,368,000
+89.5%
162,692
+25.5%
0.00%0.0%
Q3 2019$1,777,000
-4.6%
129,647
-14.4%
0.00%0.0%
Q2 2019$1,862,000
+19.5%
151,406
+21.3%
0.00%
Q1 2019$1,558,000
-65.9%
124,857
-69.1%
0.00%
-100.0%
Q4 2018$4,574,000
+53.4%
404,048
+153.6%
0.00%0.0%
Q3 2018$2,981,000
-2.7%
159,339
+34.4%
0.00%0.0%
Q2 2018$3,064,000
+33.3%
118,537
+15.6%
0.00%0.0%
Q1 2018$2,299,000
+39.2%
102,576
+55.6%
0.00%
Q4 2017$1,651,000
+20.3%
65,915
+16.1%
0.00%
Q3 2017$1,372,000
+11.8%
56,756
-6.5%
0.00%
Q2 2017$1,227,000
-38.4%
60,703
-18.0%
0.00%
Q1 2017$1,991,000
+214.0%
74,036
+122.2%
0.00%
Q4 2016$634,000
-1.6%
33,319
+1.0%
0.00%
Q3 2016$644,000
+106.4%
32,978
+58.1%
0.00%
Q2 2016$312,000
-1.3%
20,859
-39.3%
0.00%
Q1 2016$316,000
-39.5%
34,383
+26.8%
0.00%
Q4 2015$522,000
+80.6%
27,111
+39.5%
0.00%
Q3 2015$289,000
-32.3%
19,440
-0.3%
0.00%
Q2 2015$427,000
-7.6%
19,491
-5.0%
0.00%
Q1 2015$462,00020,5100.00%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Novo Holdings A/S 1,500,000$36,270,0004.72%
Gagnon Advisors, LLC 108,498$2,623,0001.99%
NEXTHERA CAPITAL LP 271,136$6,556,0001.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 883,321$21,359,0001.39%
GILDER GAGNON HOWE & CO LLC 3,961,647$95,793,0001.35%
GAGNON SECURITIES LLC 144,331$3,490,0001.30%
MILLER VALUE PARTNERS, LLC 1,181,325$28,564,0001.23%
SCHOLTZ & COMPANY, LLC 55,250$1,336,0001.05%
ARDSLEY ADVISORY PARTNERS LP 175,000$4,232,0000.56%
Ratan Capital Management LP 32,077$776,0000.47%
View complete list of FLEXION THERAPEUTICS INC shareholders